News

Advice to clinicians on risk assessment for severe COVID-19 in patients with haemoglobinopathies and inherited rare anaemias

Haemoglobinopathy HCCs advice on risk assessment COVID-19 28.08.20 This information has been produced following virtual meetings with representatives from the Haemoglobinopathy Co-ordinating Centres (HCCs) for Haemoglobin Disorders, the Clinical Reference Group for Haemoglobin Disorders, the National Haemoglobinopathy Panel, NHS Screening Committee and NHSBT as well as national experts on Sickle Cell Disease, Thalassaemia and Rare …

Advice to clinicians on risk assessment for severe COVID-19 in patients with haemoglobinopathies and inherited rare anaemias Read More »

STSTN Red Cell newsletter Easter Edition issue 14

We are pleased to announce the release of our new STSTN Red Cell Easter edition newsletter. This edition has lots of informative information regarding COVID-19 and the latest news around the STSTN network. Download and read here We hope you enjoy this edition!!

COVID-19 & Guidlines for (Sickle Cell Disease & Thalassaemia)

Patients are asking for letter for work, but instead should be told to let employers know that they are following government advice (below): We are advising those who are at increased risk of severe illness from coronavirus (COVID-19) to be particularly stringent in following social distancing measures. This group includes those who are: aged 70 …

COVID-19 & Guidlines for (Sickle Cell Disease & Thalassaemia) Read More »

Scroll to Top